← Back to headlines
Market Analysts View Stevanato Group Rally as Overreaction to Oral GLP-1 Launches
Investment firm Riverwater characterizes the recent surge in Stevanato Group stock as a market overreaction following the commercial rollout of oral GLP-1 diabetes medications.
1 Sept, 12:50 — 1 Sept, 12:50
Sources
Showing 1 of 1 sources
Related Stories
Apple Approves Compensation Packages for New CEO Ternus and Chair Cook
33m ago
Renewed US-Iran Strikes Spark Oil Surge and Market Turmoil
38m ago
US Treasury Secretary Urges Bank of Japan to Maintain Sound Monetary Policy Amid Yen Volatility
2h ago
BOJ to debate rate rise, inflation much closer to 2% target: governor
3h ago